Monday Jul 21
Applied Clinical Trials
Sequenom Laboratories Expands International Noninvasive Prenatal...
New Data Supporting the Clinical Validity of Sequenom Laboratories' Noninvasive Prenatal Tests Presented at the 18th International Conference on Prenatal Diagnosis and Therapy New Data Supporting the Clinical Validity of Sequenom Laboratories' Noninvasive Prenatal Tests Presented at the 18th International Conference on Prenatal Diagnosis and ... (more)
Monday Jul 21
Sequenom Labs Reports Expanded Int'l Noninvasive Prenatal Testing Service with VisibiliT Test
Sequenom, Inc. , a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, Sequenom Laboratories, will soon launch the VisibiliTa laboratory-developed test in international markets.
Edico Genome Raises $10 Million in Series A Financing to...
Edico Genome announced today that it has raised $10 million in a Series A financing to commercialize its DRAGEN Bio-IT Processor, the world's first next-generation sequencing bioinformatics application-specific integrated circuit .
The Motley Fool
Why Sequenom, Inc. Shares Could Soar 25%
While Fools should generally take the opinion of Wall Street with a grain of salt, it's not a bad idea to take a closer look at particularly stock-shaking analyst upgrades and downgrades -- just in case their reasoning behind the call makes sense.
Sequenom Receives New Coverage from Analysts at Jefferies Group
A number of other firms have also recently commented on SQNM. Analysts at William Blair upgraded shares of Sequenom from a "market perform" rating to an "outperform" rating in a research note on Monday, June 23rd.